Deng, Jun
Lin, Xu
Li, Qi
Cai, Xiao-yu
Wu, Lin-wen
Wang, Wei
Zhang, Bo
Li, Yang-ling
Hu, Jian
Lin, Neng-ming
Funding for this research was provided by:
National Natural Science Foundation of China (81702887)
Natural Science Foundation of Zhejiang Province (LTY21H160001)
Scientific and Technological Developing Scheme of Hangzhou City (20191203B49)
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province (2020E10021)
Science Research Foundation of Zhejiang Health Bureau (2020RC026)
Article History
Received: 20 December 2021
Accepted: 6 May 2022
First Online: 14 May 2022
Declarations
:
: The Ethics Committee of Hangzhou First People's Hospital have approved this study. (registration number: IIT-20210907-0031-01; registration date: 2021.09.13).
: Not applicable.
: The authors declare that they have no competing interests.